Prudential Financial’s Oric Pharmaceuticals ORIC Stock Holding History

Prudential Financial’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$205K	Sell	18,925 -77,220	-80%	-$700K	﹤0.01%	2224
2026 Q1	$1.22M	Buy	+96,145	New	+$1.09M	﹤0.01%	1531
2022 Q1	–	Sell	-35,230	Closed	-$564K	–	2668
2021 Q4	$564K	Sell	35,230 -205	-0.6%	-$3.2K	﹤0.01%	2153
2021 Q3	$741K	Buy	35,435 +380	+1%	+$7.7K	﹤0.01%	1969
2021 Q2	$620K	Buy	35,055 +270	+0.8%	+$5.92K	﹤0.01%	2056
2021 Q1	$852K	Buy	34,785 +100	+0.3%	+$3.16K	﹤0.01%	1917
2020 Q4	$1.17M	Buy	+34,685	New	+$995K	﹤0.01%	1675

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Prudential Financial's ORIC Position: Q2 2026 in Review

Prudential Financial reduced its Oric Pharmaceuticals (ORIC) stake by 80% in Q2 2026, selling an estimated $700K and leaving 18,925 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #2224.

Prudential Financial first reported a position in ORIC in Q4 2020 and has held it in 7 quarters since. The position peaked at $1.22M in Q1 2026. 181 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

Prudential Financial held 18,925 shares of Oric Pharmaceuticals worth $205K as of Q2 2026.
Prudential Financial sold 77,220 Oric Pharmaceuticals shares in Q2 2026, an estimated $700K.
Oric Pharmaceuticals made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2224 holding.
Prudential Financial first reported a position in Oric Pharmaceuticals in Q4 2020 and has held it in 7 quarters since.
Prudential Financial's Oric Pharmaceuticals position peaked at $1.22M in Q1 2026.
181 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.